Feature
Video
Author(s):
Rob DeWig, VP of Healthcare Sales at Inmar, touches on how access to 25% of benchmarking data from national pharmacy claims change for Premier Members.
Pharmaceutical Executive: How does access to 25% of benchmarking data from national pharmacy claims change for Premier members?
Rob DeWig: The insights that we can bring you know healthcare and really the world is full of data. And so how data without Insights is kind of cheap. And so byhaving the, 25% if you think about, if you take out some of those really big chains, that's about 25% so just saying that the insights that we can pull from that and efficiencies, that we can bring to help recoup those dollars is critical. And you know, benchmarking, not only for the retail chains, but the scope of health system outpatient pharmacies that we now have, using our revenue cycle management, we can really. Because it's just such a different business than if you go to a retail chain pharmacy, you know the goal of many of these health systems is keep those services in house. And so you know, as a patient is discharged or they're seeing a physician with that health system to make sure they're filling their prescription there. And so, we try to close the whole loop there and make sure that, not only through benchmarking, helping them get different insights into how to better run their business, but also making sure that we're helping them reduce their write offs and those type things
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.